Tag Archive for: list prices

Novo to discontinue long-acting insulin injection Levemir by the end of 2024

,

Novo Nordisk will discontinue its long-acting insulin treatment Levemir in the U.S. by the end of next year, the company announced Wednesday.

Read more
/by

AbbVie’s Humira gets a U.S. rival, but costs could stay high

, , ,

U.S. patients will finally get access to cheaper versions of AbbVie Inc.’s blockbuster arthritis drug Humira this year, but the cost savings are expected to be limited.

Read more
/by